Allurion started at buy by Roth MKM over weight-loss device potential Source: Seekingalpha
Browsing: started
aTyr started at buy by Jefferies, citing efzofitimod potential Source: Seekingalpha
Amicus started at buy by Jefferies, viewed as “development at reasonable value” Source: Seekingalpha
Allurion started at buy by Roth MKM over weight-loss device potential Source: Seekingalpha
aTyr started at buy by Jefferies, citing efzofitimod potential Source: Seekingalpha
Genelux started at buy by Roth MKM ahead of Olvi-Vec readouts Source: Seekingalpha
Genelux started at buy by Roth MKM ahead of Olvi-Vec readouts Source: Seekingalpha
Genelux started at buy by Roth MKM ahead of Olvi-Vec readouts Source: Seekingalpha
sutthirat sutthisumdang Roth MKM started protection of Genelux (NASDAQ:GNLX) with a buy score, citing the corporate’s drug Olvi-Vec within the remedy of ovarian most cancers. The…
Kylie Kelce feels “accountable” over her sudden fame. The 31-year-old event advisor – who’s married to NFL participant Jason Kelce and has Wyatt, 4, Elliotte, three,…